Objectives-To test whether dioxins affect liver and thyroid function, lipid metabolism and glucose or immunological variables, in workers exposed to brominated dioxins and furans. Methods-34 male production employees (29 were extruder operators) and eight technical support personnel were studied, all of whom were potentially exposed to polybrominated dibenzo-p-dioxins (PBDDs) and furans (PBDFs) during production of resins containing polybrominated diphenyl ethers (PBDEs). Controls were from a similar resin producing plant that did not use PBDEs. Blood samples were analysed for tetra, penta, and hexabrominated congeners, but 2, 3, 7, dibenzo-p-dioxins are thought to exert their toxic effects through interaction with a specific intracellular protein, the Ah receptor.' Although far less toxicological and epidemiological information is available on the brominated congeners, existing evidence suggests that these compounds are only slightly less potent in toxicity than the corresponding chlorinated dioxins and that metabolic pathways are similar as well.' 2 Previously, we described biomonitoring and immunological findings for 42 employees potentially exposed to polybrominated dibenzo-p-dioxins (PBDDs) and furans (PBDFs) during extrusion blending of resins containing the flame retardant decabromodiphenyl ether.3 Among production employees measured concentrations of 2,3,7,8-tetrabromodibenzo-p-dioxin (2, 3, 7, in blood lipids ranged from nondetectable to 475 parts per trillion (ppt). The median concentration of 2,3,7,8-TBDD among 18 extruder operators first assigned to the unit before 1986 was 91 ppt.
Polyhalogenated
dibenzo-p-dioxins are thought to exert their toxic effects through interaction with a specific intracellular protein, the Ah receptor.' Although far less toxicological and epidemiological information is available on the brominated congeners, existing evidence suggests that these compounds are only slightly less potent in toxicity than the corresponding chlorinated dioxins and that metabolic pathways are similar as well.' 2 Previously, we described biomonitoring and immunological findings for 42 employees potentially exposed to polybrominated dibenzo-p-dioxins (PBDDs) and furans (PBDFs) during extrusion blending of resins containing the flame retardant decabromodiphenyl ether.3 Among production employees measured concentrations of 2,3,7,8-tetrabromodibenzo-p-dioxin (2,3,7,8-TBDD) in blood lipids ranged from nondetectable to 475 parts per trillion (ppt). The median concentration of 2,3,7,8-TBDD among 18 extruder operators first assigned to the unit before 1986 was 91 ppt.
In this report, the results of liver function tests, lipid and glucose measures, thyroid function variables, and haematological and coagulation indicators are presented in relation to exposure status and blood lipid concentration of 2,3,7,8-TBDD. These variables, together with the previously examined immunological measures, were selected for study based on evidence that dioxins exert effects on liver, thyroid, and immunological tissue and may alter lipid metabolism.
Subjects and methods
The study group consisted of 34 production employees (29 were extruder operators) and eight technical support personnel, all of whom were potentially exposed to PBDDs and PBDFs during production of resins containing polybrominated diphenyl ethers (PBDEs). Brominated flame retardants were first used in this production process during 1975; however, octa and decabromodiphenyl ethers were probably not processed before 1977. The control group was recruited from a similar resin producing plant that did not use PBDEs and consisted of an equal number of employees frequency matched to the study group by age, general type of employment, and nationality. There were no women employees in either group. The average age of study group partici- We had also examined these same laboratory variables in a study of 138 employees with previous exposure to chlorinated dioxinsnamely, 2,3,7,8-TCDD. In both instances biomonitoring data were obtained to support the characterisation of the corresponding dioxin exposures. As the distributions of 2,3,7,8-TBDD and 2,3,7,8-TCDD concentrations measured at the time of the examination were similar within the respective study groups, a comparison of findings across the two studies is of interest. However, it should be noted that the exposure circumstances giving rise to the current dioxin burdens were very different.
In the case of the chlorinated dioxin study group, exposure had occurred after a 1953 autoclave accident and the entire dioxin dose was received in a matter of days for many people in that cohort. Taking into account both the > 30 year interval between exposure and measurement of dioxin concentrations (2,3,7,8-TCDD half life estimates were calculated to be about six years in our study population) and differences in duration of exposure under the respective scenerios, it is likely that dose rates were up to three orders of magnitude higher in the 1953 accident group. This is reflected in the finding that 25% of the participants in the chlorinated dioxin study were diagnosed with severe chloracne after the accident and another 17) with moderate chloracne, whereas with the brominated dioxins no single case 
